How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
Stéphane Epelbaum, Claire Paquet, Jacques Hugon, Julien Dumurgier, David Wallon, Didier Hannequin, Thérèse Jonveaux, Annick Besozzi, Stéphane Pouponneau, Caroline Hommet, Frederic Blanc, Laetitia Berly, Adrien Julian, Marc Paccalin, Florence Pasquier, Julie Bellet, Claire Boutoleau-Bretonniere, Thiphaine Charriau, Olivier Rouaud, Olivier Madec, Aurélie Mouton, Renaud David, Samir Bekadar, Roxane Fabre, Emmanuelle Liegey, Walter Deberdt, Philippe Robert, Bruno Dubois
BMJ Open Jun 2019, 9 (6) e029663; DOI: 10.1136/bmjopen-2019-029663